OOIR: Observatory of International Research

Papers

(The TQCC of Alzheimer Disease & Associated Disorders is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Sex-related Differences in Tau Positron Emission Tomography (PET) and the Effects of Hormone Therapy (HT)	28
Expanded Demographic Norms for Version 3 of the Alzheimer Disease Centers’ Neuropsychological Test Battery in the Uniform Data Set	27
Vascular Dementia, Depression, and Financial Capacity Assessment	24
Unraveling Ariadne’s Thread Into the Labyrinth of aMCI	20
The Insular Cortex, Alzheimer Disease Pathology, and Their Effects on Blood Pressure Variability	18
Physical Exercise and Longitudinal Trajectories in Alzheimer Disease Biomarkers and Cognitive Functioning	15
Mild Alzheimer Disease, Financial Capacity, and the Role of Depression	15
Effects of Noninvasive Brain Stimulation (NIBS) on Cognitive Impairment in Mild Cognitive Impairment and Alzheimer Disease	13
Sociodemographic and Clinical Characteristics of 1350 Patients With Young Onset Dementia	13
Physical Performance and Cognition in a Diverse Cohort	12
Racial/Ethnic Disparities in Young Adulthood and Midlife Cardiovascular Risk Factors and Late-life Cognitive Domains	12
The Measurement of Everyday Cognition (ECog)	12
Patient and Relative Experiences and Decision-making About Genetic Testing and Counseling for Familial ALS and FTD	11
Bone Mineral Density Measurements and Association With Brain Structure and Cognitive Function	11
Neural Basis of Long-term Musical Memory in Cognitively Impaired Older Persons	11
Dementia Incidence in the Elderly Population of Greece	11
Predictors of Willingness to Enroll in Hypothetical Alzheimer Disease Biomarker Studies that Disclose Personal Results	9
Biomarker Use for Dementia With Lewy Body Diagnosis	8
Efficacy of Mealtime Interventions for Malnutrition and Oral Intake in Persons With Dementia	8
Androgen Deprivation Therapy Use and Risk of Mild Cognitive Impairment in Prostate Cancer Patients	8
Prevalence of Mild Cognitive Impairment in the Lothian Birth Cohort 1936	8
Confluent White Matter in Progression to Alzheimer Dementia	8
Association Between Cognitive Test Performance and Subjective Cognitive Decline in a Diverse Cohort of Older Adults	8
Clinical Care and Unmet Needs of Individuals With Dementia With Lewy Bodies and Caregivers	8
Cognitive Behavioral Therapy for Mood and Insomnia in Persons With Dementia	8

Cardiac and Blood Pressure Safety of Transdermal Rivastigmine in Elderly Patients With Dementia With Lewy Bodies	7
Intravesical BCG and Incidence of Alzheimer Disease in Patients With Bladder Cancer	7
Outcome Measures for Dementia With Lewy Body Clinical Trials	7
Staging of Dementia Severity With the Hong Kong Version of the Montreal Cognitive Assessment (HK-MoCA)’s	7
An Initial Empirical Operationalization of the Earliest Stages of the Alzheimer’s Continuum	7
Assessment of Functional Near-infrared Spectroscopy by Comparing Prefrontal Cortex Activity	7
Value of a Panel of 6 Serum Biomarkers to Differentiate Between Healthy Controls and Mild Cognitive Impairment Due to Alzheimer Disease	7
Do the Benefits of Educational Attainment for Late-life Cognition Differ by Racial/Ethnic Group?	6
Long-term Neuropsychiatric Complications and 18F-FDG-PET Hypometabolism in the Brain From Prolonged Infection of COVID-19	6
Beliefs, Understanding, and Barriers Related to Dementia Research Participation Among Older African Americans	6
Genetic Variants Associated With Alzheimer Disease in the 22 Arab Countries	6
The Association Between Patterns of Social Engagement and Conversion From Mild Cognitive Impairment to Dementia	6
Functional Decline and Body Composition Change in Older Adults With Alzheimer Disease	6
Meta-analysis of the Connection Between Alzheimer Disease and Telomeres	6
Genetic Variants and Haplotypes of TOMM40, APOE, and APOC1 are Related to the Age of Onset of Late-onset Alzheimer Disease in a Colombian Population	6
Validity of the Mini-Mental State Examination-2 in Diagnosing Mild Cognitive Impairment and Dementia in Patients Visiting an Outpatient Clinic in the Netherlands	6
Right Temporal Lobe Variant of Frontotemporal Dementia	5
Clinical Profiles of Arteriolosclerosis and Alzheimer Disease at Mild Cognitive Impairment and Mild Dementia in a National Neuropathology Cohort	5
Cerebral Amyloid Angiopathy-related Inflammation Presenting With a Cystic Lesion in Young-onset Alzheimer Disease	5
Association of Dementia and Vascular Risk Scores With Cortical Thickness and Cognition in Low-risk Middle-aged Adults	5
Perceptions of Research Burden and Retention Among Participants in ADRC Cohorts	5
Comparison of the Accuracy of Short Cognitive Screens Among Adults With Cognitive Complaints in Turkey	5
Exercise and the Risk of Mild Cognitive Impairment	5
Obesity and Oxidative Stress in Older Adults At Risk for Dementia	4
Evaluation of the Clinical Features Accompanied by the Gene Mutations	4
Association Between GlycA and Cognitive Function	4
Association Between Adherence to the MIND Diet and Cognitive Performance is Affected by Income	4
Predicting Mental Decline Rates in Mild Cognitive Impairment From Baseline MRI Volumetric Data	4
Evolving Causes of Rapidly Progressive Dementia	4
Polymorphism in the MAGI2 Gene Modifies the Effect of Amyloid β on Neurodegeneration	4
Subtle Changes in Medication-taking Are Associated With Incident Mild Cognitive Impairment	4
Novel PSEN1 and PSEN2 Mutations Identified in Sporadic Early-onset Alzheimer Disease and Posterior Cortical Atrophy	4
Physical and Vestibular Physical Therapy Referrals in People With Alzheimer Disease	4
Using Direct-to-Consumer Genetic Testing Results to Accelerate Alzheimer Disease Clinical Trial Recruitment	4
Impact of Disturbed Rest-activity Rhythms on Activities of Daily Living in Moderate and Severe Dementia Patients	4
Early Impairment in the Ventral Visual Pathway Can Predict Conversion to Dementia in Patients With Amyloid-negative Amnestic Mild Cognitive Impairment	4
Phase 1 Single Ascending and Multiple Ascending Dose Studies of Phosphodiesterase-9 Inhibitor E2027	4